Monday, February 6, 2023
HomeRoboticsImVitro Raises $2.5M to Enhance IVF Course of With AI

ImVitro Raises $2.5M to Enhance IVF Course of With AI


Deep-tech firm ImVitro has introduced a $2.5M seed spherical led by LDV Capital, with co-investors together with MMC Ventures, Tiny VC, Fly Ventures, and Compound VC. The corporate consists of a dozen consultants concerned with AI, medtech, and regulatory affairs. The crew is led by Dr. Alexandra Boussommier, a biomedical engineer educated in Switzerland, the UK and the US. 

EMBRYOLY Platform for IVF Course of

ImVitro developed the B2B SaaS platform EMBRYOLY, which applies laptop imaginative and prescient and synthetic intelligence (AI) to the IVF fertility imaging course of. The corporate works to attenuate failed transfers within the IVF course of, in addition to enhance high quality management and transparency for sufferers. 

Over a dozen clinics in Europe depend on EMBRYOLY, with greater than 1,500 IVF cycles being processed by the platform. 

ImVitro developed an working system that mixes cell tradition and AI to handle infertility. The method includes AI-powered automation within the embryo analysis course of with EMBRYOLY analyzing movies from microscopes to save lots of time for clinicians whereas growing transparency. This course of additionally eliminates human errors and delivers dependable predictions. Clinics may also use the platform to offer entry to a affected person portal that delivers simplified lab outcomes. 

The platform is CE marked and has benchmarked its efficiency towards 13 embryologists in a retrospective scientific trial. 

Whereas different options are restricted to visible info or the affected person’s age, ImVitro can analyze greater than 30 scientific knowledge factors to create a hybrid rating. These knowledge factors embrace the affected person’s BMI, uterus receptivity, spermatozoa mobility, and extra. All of this results in improved accuracy and personalised and standardized outcomes. 

Dr. Alexandra Boussommier can be Founder and CEO of ImVitro. 

“By taking into consideration knowledge concerning the sufferers and their therapy, EMBRYOLY predicts extra precisely the probabilities an embryo has to result in a being pregnant and gives extra clear and personalised suggestions,” Dr. Boussommier mentioned. 

The brand new funding will go in direction of including new hires within the technical and gross sales crew. It’ll additionally assist the corporate broaden to the U.S. market and develop new options for the software program. 

“We’re very excited to be coming into this new chapter that can consolidate our AI-driven software program not solely as a device that minimizes failed IVF remedies, but additionally one which will increase workflow effectivity within the IVF lab and gives a bridge between medical doctors and sufferers so as to add transparency to the complicated multi-step course of that’s IVF,” Dr. Boussommier continued.

Dr. Xavier Pollet-Villard is Director of the Nataliance IVF and Andrology laboratory. 

“ImVitro helps embryologists and sufferers at our clinic to navigate the complicated strategy of IVF,” he says. “It not solely will increase the effectivity of the work that we do but additionally gives much-needed transparency. Their AI-powered platform EMBRYOLY seamlessly connects to our expertise stack and helps us make data-driven selections about embryos that we observe in our lab which then result in profitable pregnancies.”

Phrases From Buyers

Evan Nisselson is Founder and Normal Accomplice at LDV Capital.

“We at LDV Capital are thrilled to accomplice with Dr. Alexandra Boussommier and the good crew at ImVitro to deliver EMBRYOLY to market throughout the globe so thousands and thousands of individuals can enhance their probability of getting a profitable being pregnant via the IVF Fertility course of,” mentioned Nisselson. “ImVitro will ship a leapfrog technical resolution to the IVF fertility imaging course of by leveraging laptop imaginative and prescient and synthetic intelligence which has been a core experience of our LDV Capital agency since being based in 2012.”

Charlotte Barttelot is Principal at MMC Ventures.

“We’ve been researching the fertility panorama, and the IVF course of has not improved for the reason that first IVF child over 40 years in the past,” Barttelot mentioned. “ImVitro’s crew combines deep-tech experience and entrepreneurship, leveraging laptop imaginative and prescient and AI to extend the share of profitable pregnancies. We’re proud to be a part of their journey.”

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments